CoChat

Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment

Open access
Iommarini, Luisa, Kurelac, Ivana, Capristo, Mariantonietta, Calvaruso, Maria Antonietta, Giorgio, Valentina, Bergamini, Christian, Ghelli, Anna, Nanni, Patrizia, De Giovanni, Carla, Carelli, Valerio, Fato, Romana, Lollini, Pier Luigi, Rugolo, Michela, Gasparre, Giuseppe, Porcelli, Anna Maria · 2014 · Human Molecular Genetics
Cited by 102

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Mitochondrial DNA mutations are currently investigated as modifying factors impinging on tumor growth and aggressiveness, having been found in virtually all cancer types and most commonly affecting genes encoding mitochondrial complex I (CI) subunits. However, it is still unclear whether they exert a pro- or anti-tumorigenic effect. We here analyzed the impact of three homoplasmic mtDNA mutations (m.3460G>A/MT-ND1, m.3571insC/MT-ND1 and m.3243A>G/MT-TL1) on osteosarcoma progression, chosen since they induce different degrees of oxidative phosphorylation impairment. In fact, the m.3460G>A/MT-ND1 mutation caused only a reduction in CI activity, whereas the m.3571insC/MT-ND1 and the m.3243A>G/MT-TL1 mutations induced a severe structural and functional CI alteration. As a consequence, this severe CI dysfunction determined an energetic defect associated with a compensatory increase in glycolytic metabolism and AMP-activated protein kinase activation. Osteosarcoma cells carrying such marked CI impairment displayed a reduced tumorigenic potential both in vitro and in vivo, when compared with cells with mild CI dysfunction, suggesting that mtDNA mutations may display diverse impact on tumorigenic potential depending on the type and severity of the resulting oxidative phosphorylation dysfunction. The modulation of tumor growth was independent from reactive oxygen species production but correlated with hypoxia-inducible factor 1α stabilization, indicating that structural and functional integrity of CI and oxidative phosphorylation are required for hypoxic adaptation and tumor progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddt533

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 102

Metadata

Authors
Iommarini, L., Kurelac, I., Capristo, M., Calvaruso, M. A., Giorgio, V., Bergamini, C., Ghelli, A., Nanni, P., De Giovanni, C., Carelli, V., Fato, R., Lollini, P. L., Rugolo, M., Gasparre, G., & Porcelli, A. M.
Venue
Human Molecular Genetics
Published
2013-10-24
Volume
23
Issue
6
Pages
1453-1466
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2151568543
Cited by
102
References
17
FWCI
3.36
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment. https://app.cochat.ai/papers/10.1093/hmg/ddt533
The paper
Iommarini, L., Kurelac, I., Capristo, M., Calvaruso, M. A., Giorgio, V., Bergamini, C., Ghelli, A., Nanni, P., De Giovanni, C., Carelli, V., Fato, R., Lollini, P. L., Rugolo, M., Gasparre, G., & Porcelli, A. M. (2014). Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddt533

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.